HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Benoit Guibert Pierre Mulsant Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perrot, E. Articles by Souquet, P.-J. Search for Related Content PubMed PubMed Citation Articles by Perrot, E. Articles by Souquet, P.-J. Related Collections Lung - cancer

Ann Thorac Surg 2005;80:423-427
© 2005 The Society of Thoracic Surgeons

---

Original article: General thoracic

Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection

^a Department of Thoracic Oncology and Chest Disease, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Benite, France
^b Thoracic Surgery Unit, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Benite, France
^c Department of Biostatistics, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Benite, France

Accepted for publication February 9, 2005.

^_* Address reprint requests to Dr Perrot, Department of Thoracic Oncology and Chest Disease, Hospices Civils de Lyon, Pneumologie 1A, Secteur JC, Chemin du Grand Revoyet, Centre Hospitalier Lyon Sud, Pierre Benite, 69495 Cedex France (Email: emilie.perrot{at}chu-lyon.fr).

BACKGROUND: Neoadjuvant chemotherapy before resection of nonsmall cell lung cancer seems to increase survival, mainly in the early stage. Risks of postoperative complications after chemotherapy and surgery remain controversial. Here we review our experience with patients treated in one thoracic surgery center.

METHODS: Patients undergoing resection for nonsmall cell lung cancer after induction chemotherapy between January 1993 and March 2002 were reviewed. Data collected included age, sex, preoperative forced expiratory volume in 1 second (FEV₁), hemoglobin, and arterial oxygen pressure tension (PaO₂), postoperative complications, and global survival.The main objectives were postoperative mortality and morbidity. Postoperative mortality and morbidity were defined as complications or deaths occurring within 30 days after surgery. Predictive morbidity factors were identified by univariate and multivariate analysis and overall survival by the Kaplan-Meier method.

RESULTS: In all, 114 patients were reviewed. Different induction chemotherapies were used, mainly cisplatin with vinorelbine or gemicitabine. Postoperative mortality was 2 of 114, 1 of 27 after pneumonectomy, and there were no deaths after lobectomy. Complications occurred in 29% of patients (33 of 114), usually infectious pneumonia and anemia requiring transfusion. Preoperative FEV₁, hemoglobin, and PaO₂ are not associated with morbidity in univariate or multivariate analysis.

CONCLUSIONS: Preoperative chemotherapy does not increase postoperative mortality and morbidity after nonsmall cell lung cancer surgery, performed exclusively by thoracic surgeons.

This article has been cited by other articles:

				A. W. Kim, L. P. Faber, W. H. Warren, S. Basu, S. C. Wightman, J. A. Weber, P. Bonomi, and M. J. Liptay Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter? Ann. Thorac. Surg., September 1, 2009; 88(3): 937 - 943. [Abstract] [Full Text] [PDF]

				H. A. Gaissert, D. Y. Keum, C. D. Wright, M. Ancukiewicz, E. Monroe, D. M. Donahue, J. C. Wain, M. Lanuti, J. S. Allan, N. C. Choi, et al. POINT: Operative risk of pneumonectomy--influence of preoperative induction therapy. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 289 - 294. [Abstract] [Full Text] [PDF]

				A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur. Respir. J., July 1, 2009; 34(1): 17 - 41. [Abstract] [Full Text] [PDF]

				T. Gudbjartsson, E. Gyllstedt, A. Pikwer, and P. Jonsson Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Ann. Thorac. Surg., August 1, 2008; 86(2): 376 - 382. [Abstract] [Full Text] [PDF]

				F. Venuta, M. Anile, D. Diso, M. Ibrahim, T. De Giacomo, M. Rolla, V. Liparulo, and G. F. Coloni Operative complications and early mortality after induction therapy for lung cancer Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 714 - 717. [Abstract] [Full Text] [PDF]

				Z. Mansour, E. A. Kochetkova, X. Ducrocq, M.-D. Vasilescu, G. Maxant, A. Buggenhout, J.-M. Wihlm, and G. Massard Induction chemotherapy does not increase the operative risk of pneumonectomy! Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 181 - 185. [Abstract] [Full Text] [PDF]

				A. Dulu, S. M. Pastores, B. Park, E. Riedel, V. Rusch, and N. A. Halpern Prevalence and Mortality of Acute Lung Injury and ARDS After Lung Resection. Chest, July 1, 2006; 130(1): 73 - 78. [Abstract] [Full Text] [PDF]

				A. Brunelli, F. Xiume', M. Al Refai, M. Salati, R. Marasco, and A. Sabbatini Gemcitabine-Cisplatin Chemotherapy Before Lung Resection: A Case-Matched Analysis of Early Outcome Ann. Thorac. Surg., June 1, 2006; 81(6): 1963 - 1968. [Abstract] [Full Text] [PDF]

				F. Leo, A. Borri, F. Petrella, R. Gasparri, D. Galetta, G. Veronesi, and L. Spaggiari Preoperative Chemotherapy and Postoperative Complications: A Closer Look Ann. Thorac. Surg., June 1, 2006; 81(6): 2335 - 2335. [Full Text] [PDF]